Sitoredüktif Cerrahi ile Birlikte Hipertermik İntraperitoneal Kemoterapi Uygulanan Hastada Anestezi Yönetimi: Olgu Sunumu

Ali Genç

Olgu Sunumu

Anesthesia Management, in a Patient Who was Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Case Report

Yıl 2021, Cilt: 13 Sayı: 2, 113 - 119, 19.10.2021

Ali Genç

Öz

Treatment of peritoneal surface malignancies with cytoreductive surgery with hyperthermic intraperitoneal chemotherapy has been used since the 1990s, but has been more preferred in recent years. These patients may experience perioperative hypothermia, hyperthermia, fluid shifts, coagulopathy, electrolyte disturbances, renal dysfunction and severe pain in the postoperative period. Therefore, anesthesia management is quite complicated. Here, we presented our peroperative anesthesia management in a 33-year-old patient diagnosed with gastric adenocarcinoma accompanied by peritoneal carcinomatosis.

Anahtar Kelimeler

Anesthesia, regional perfusion antineoplastic chemotherapy, peritoneal neoplasms

Kaynakça

1. Web CA, Weyker PD, Moitra VK, Raker RK. An Overview of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for the Anesthesiologist Anesth Analg. 2013; 116: 924-931.
2. Elias D, Blot F, Otmany AE, Antoun S, Lasser P, Boige V et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001; 92(1): 71-76.
3. Sugarbaker PH. Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach. Expert Opin Pharmacother. 2009; 10(12): 1965-1977.
4. Dehal A, Smith JJ, Nash GM. Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future. J Gastrointest Oncol. 2016; 7(1): 143-157.
5. Lambert LA. Looking up: recent advances in understanding and treating peritoneal carcinomatosis. CA Cancer J Clin. 2015; 65(4): 284-298.
6. Huang CQ, Min Y, Wang SY, Yang XL, Liu Y, Xiong B et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence. Oncotarget 2017; 8(33): 55657-55683.
7. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary—a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Anesth Analg 2008; 106: 685-712.
8. Esquivel J, Angulo F, Bland RK Stephens AD, Sugarbaker PH. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open “coliseum technique.” Ann Surg Oncol 2000; 7: 296-300.
9. Schmidt C, Creutzenberg M, Piso P Hobbhahn J, Bucher M. Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia 2008; 63: 389-395.
10. Miao N, Pingpank JF, Alexander HR, Royal R, Steinberg SM, Quezado MM et al. Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and Anesthetic Considerations. Ann Surg Oncol 2009; 16: 334-344.
11. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28(1): 63-68.
12. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 2009; 27 (36): 6237-6242.
13. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15(9): 2426-2432.
14. Ryu KS, Kim JH, Ko HS, Kim JW, Ahn WS, Park YG et al. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 2004; 94(2): 325-332.
15. Maciver AH, Al-Sukhni E, Esquivel J, Skitzki JJ,Kane JM, Francescutti VA. Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons. Annals of Surgical Oncology 2017; 24: 923–930. 16. Moradi BN, Esquivel J. Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surg Oncol 2009; 100(4): 293–296.
16. Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, Morris DL et al. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei. Br J Surg. 2014; 101(13): 1758–1765.
17. Esquivel J. Current status and future directions of hyperthermic intraperitoneal chemotherapy (HIPEC). Int Oncol. 2014; 2(6): 45–52.
18. Esquivel J, Stojadinovic A, Levine EA. The American Society of Peritoneal Surface Malignancies (ASPSM). Ann Surg Oncol. 2011; 3: 218–219.
19. Huang CQ, Min Y, Wang SY, Yang XJ, Liu Y, Xiong B et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence. Oncotarget 2017; 8(33): 55657-55683.
20. Kanakoudis F, Petrou A, Chortaria G, Konstantinido A. Konstantinido. Anaesthesia for intra-peritoneal perfusion of hyperthermic chemotherapy. Haemodynamic changes, oxygen consumption and delivery. Anaesthesia 1996; 51 (11): 1033-1036.
21. Lucillia B, Mégane R, Myriam D,Bernard C, Romain P. Haemodynamic management during hyperthermic intraperitoneal chemotherapy: A systematic review. Anaesthesia Critical Care & Pain Medicine 2020; 39: 531-542.
22. Owusu-Agyemang P, Arunkumar R, Green H Green H, Hurst D, Landoski K, Hayes-Jordan A. Anesthetic management and renal function in pediatric patients undergoing cytoreductive surgery with continuous hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin. Ann Surg Oncol 2012; 19: 2652–2656.
23. Said ET, Sztain JF, Abramson WB, Meineke MN, Furnish TJ, Schmidt UH, et al. A dedicated acute pain service is associated with reduced postoperative opioid requirements in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anesth Analg. 2018; 127(4): 1044–1050.
24. Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C et al. Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations--part II. Gynecol Oncol. 2016; 140(2): 323–332.
25. Piccioni F, Casiraghi C, Fumagalli L, Kusamura S, Baratti D, Deraco M et al. Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy. Int J Surg 2015; 16: 99-106.
26. Raspe C, Flother L, Schneider R, Bucher M, Piso p. Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol. 2017; 43(6): 1013–1027.
27. Ali M, Winter DC, Hanly AM, O’Hagan C, Keaveny J, Broe P. Prospective, randomized, controlled trial of thoracic epidural or patient-controlled opiate analgesia on perioperative quality of life. Br J Anaesth. 2010; 104(3): 292–297. 29. Jakobsson J, Wickerts L, Forsberg S, Ledin G. Transversus abdominal plane (TAP) block for postoperative pain management: a review. F1000Res 2015; 26: 24.